Dilraj Grewal, MD Associate Professor of Ophthalmology Duke Eye Center The Uveitis Subspecialty day Avant-Garde Blues session included late breaking talks on uveitis trials. Suprachoroidal Delivery of CLS-TA for Uveitic…
Brian K. Do, MD The Retina Group of Washington Dr. Arshad Khanani, MD, of Sierra Eye Associates, in Reno, NV, presented these promising phase 2 data in one of the…
Cynthia X. Qian, MD Assistant Professor of Ophthalmology University of Montreal The “First-Time Results of Clinical Trials” session had two presentations from Allergan trials. The first talk introduced the Phase…
Yoshihiro Yonekawa, MD Mass Eye & Ear / Boston Children’s RETINA Roundup Co-Editor The age-related macular degeneration (AMD) session at Retina Society is always jam-packed. Patients with AMD comprise a…
Hossein Nazari Khanamiri, MD Ophthalmology Resident UTMB Ophthalmology and Visual Sciences The late breaking session is reserved for high-profile and potentially industry-moving clinical trial data that becomes available often after…
The use of anti-VEGF therapy has revolutionized the treatment of wet AMD, such that most patients can now maintain functional vision for their lifetimes. However, the need for frequent injections…
Nitish Mehta, MD Ophthalmology Resident New York University Yasha Modi, MD Assistant Professor of Ophthalmology New York University Yesterday we reported on the favorable Phase II results from Genentech’s BOULEVARD…
Nitish Mehta, MD Ophthalmology Resident New York University Yasha Modi, MD Assistant Professor of Ophthalmology New York University Many companies are working to fill unmet needs in the treatment of…
